Prostate Cancer

>

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Latest News

The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and fewer bone metastases: © stock.adobe.com.
Bone Metastasis Count May Guide Erleada Treatment in Prostate Cancer

May 14th 2025

The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and fewer bone metastases.

Photo of a patient in consultation with a doctor.
Decipher Prostate Test Now Available for Metastatic Prostate Cancer

April 25th 2025

The first patient has been enrolled in the ARID II trial for prostate cancer: stock.adobe.com.
First Patient Enrolled in ARID II Trial for Prostate Cancer Treatment

April 24th 2025

Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate cancer.
Erleada Reduces Risk of Death in Metastatic Prostate Cancer Subset

April 15th 2025

Image of man.
Nubeqa Combo Improves Outcomes in Metastatic Prostate Cancer

April 15th 2025

Educated Patient Resource Guide

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Resource guide for prostate cancer

More News